Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort.
Laihui LuoRenfeng ShanLifeng CuiZhao WuJunlin QianShuju TuWenJian ZhangYuanpeng XiongWei LinHongtao TangYang ZhangJisheng ZhuZeyu HuangZhigang LiShengping MaoHui LiZemin HuPeng PengKun HeYong LiLiping LiuWei ShenYongzhu HePublished in: United European gastroenterology journal (2023)
Postoperative adjuvant transarterial chemoembolisation has a good safety profile and may be a potentially beneficial treatment modality for survival outcomes in patients with HCC, especially those with concomitant MVI.